Bristol-Myers Squibb Co. v. Novartis Pharma AG
| Bristol-Myers Squibb Co. |
| Novartis Pharma AG |
| 1:2022cv04162 |
| May 20, 2022 |
| US District Court for the Southern District of New York |
| Colleen McMahon |
| Other Statutes: Arbitration |
| 9 U.S.C. ยง 9 Motion to Confirm Arbitration Award |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 13, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 16
NOTICE OF VOLUNTARY DISMISSAL pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, against the defendant(s) Novartis Pharma AG. Document filed by Bristol-Myers Squibb Co.. Proposed document to be reviewed and processed by Clerk's Office staff (No action required by chambers)...(Bowen, Lamina)
|
|
Filing 15
MEMORANDUM DECISION AND ORDER DENYING RESPONDENT'S MOTION FOR RECONSIDERATION re: #14 MOTION for Reconsideration re; #13 Order on Motion to Seal, . filed by Novartis Pharma AG. Novartis' motion for reconsideration is denied. The clerk is respectfully directed to close the open motion at Docket Number 14. Novartis' alternative request to redact the royalty information from pages 16, 20, 22-23, 25-26 and 28 of the award, along with information about sales amounts is granted. If and when the final award is filed, the parties are directed to file it with these limited redactions and to redact the same information in any papers filed on the docket. The Court is to be provided with unredacted courtesy copies in all instances. This is the opinion and order of the Court. It is a written opinion. (Signed by Judge Colleen McMahon on 6/23/2022) (ate)
|
|
Filing 14
MOTION for Reconsideration re; #13 Order on Motion to Seal,,, . Document filed by Novartis Pharma AG..(Simes, Jeffrey)
|
|
Filing 13
MEMORANDUM DECISION AND ORDER DENYING RESPONDENT'S MOTION TO SEAL THE FINAL ARBITRATION AWARD: denying #7 Motion to Seal. Novartis's motion to seal the final arbitration award is DENIED. Novartis' alternative request to file a redacted version of the final award is also DENIED except to the extent of allowing it to redact the sales amounts found on page 17 of the award. Novartis has until June 22, 2022 to inform the Court whether it wants the royalty information redacted where it appears at pages 16, 20, 22-23, 25-26, and 28. To that extent, the motion is GRANTED. The clerk is respectfully directed to close the open motion at Docket Number 7. This constitutes the decision and order of the Court. It is a written opinion. (Signed by Judge Colleen McMahon on 6/14/2022) (ama)
|
|
Filing 12
ORDER SCHEDULING AN INITIAL PRETRIAL CONFERENCE: Parties should dial in at 1(888)363-4749, access code (9054506) to join the conference. (And as further set forth herein.) Initial Conference set for 10/6/2022 at 10:15 AM before Judge Colleen McMahon. (Signed by Judge Colleen McMahon on 6/7/2022) (jca)
|
|
Filing 11
NOTICE OF APPEARANCE by Jeffrey A. Simes on behalf of Novartis Pharma AG..(Simes, Jeffrey)
|
|
Filing 10
NOTICE OF APPEARANCE by Alexandra Daloia Valenti on behalf of Novartis Pharma AG..(Valenti, Alexandra)
|
|
Filing 9
RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Novartis AG for Novartis Pharma AG. Document filed by Novartis Pharma AG..(Valenti, Alexandra)
|
|
Filing 8
***SELECTED PARTIES*** MEMORANDUM OF LAW in Support re: #7 MOTION to Seal Arbitration Award. . Document filed by Novartis Pharma AG, Bristol-Myers Squibb Co.. (Attachments: #1 Supplement Declaration of Jeffrey A. Simes in Support of Unopposed Motion to File Arbitration Award Under Seal, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)Motion or Order to File Under Seal: #7 .(Simes, Jeffrey)
|
|
Filing 7
MOTION to Seal Arbitration Award. Document filed by Novartis Pharma AG..(Simes, Jeffrey)
|
|
Filing 6
ELECTRONIC SUMMONS ISSUED as to Novartis Pharma AG..(pc)
|
|
Magistrate Judge James L. Cott is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: #https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (pc)
|
|
CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Colleen McMahon. Please download and review the Individual Practices of the assigned District Judge, located at #https://nysd.uscourts.gov/judges/district-judges. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at #https://nysd.uscourts.gov/rules/ecf-related-instructions..(pc)
|
|
Case Designated ECF. (pc)
|
|
Filing 5
REQUEST FOR ISSUANCE OF SUMMONS as to Novartis Pharma AG, re: #1 Petition to Compel/Confirm/Modify/Stay/Vacate Arbitration. Document filed by Bristol-Myers Squibb Co...(Bowen, Lamina)
|
|
Filing 4
RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Bristol-Myers Squibb Co...(Bowen, Lamina)
|
|
Filing 3
CIVIL COVER SHEET filed..(Bowen, Lamina)
|
|
Filing 2
NOTICE of Petition re: #1 Petition to Compel/Confirm/Modify/Stay/Vacate Arbitration. Document filed by Bristol-Myers Squibb Co...(Bowen, Lamina)
|
|
Filing 1
PETITION TO CONFIRM ARBITRATION. (Filing Fee $ 402.00, Receipt Number ANYSDC-26177904).Document filed by Bristol-Myers Squibb Co.. (Attachments: #1 Exhibit 1).(Bowen, Lamina)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Bristol-Myers Squibb Co. v. Novartis Pharma AG | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Petitioner: Bristol-Myers Squibb Co. | |
| Represented By: | Lamina E Bowen |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Respondent: Novartis Pharma AG | |
| Represented By: | Jeffrey A. Simes |
| Represented By: | Alexandra Daloia Valenti |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
